Blog

It’s up to the IRS to ensure that nonprofits are not being used as illicit vehicles to funnel untraceable money into our elections. However the agency’s handling of this responsibility has been thoroughly outrageous, the latest scandal being just the latest example of disturbing action—or, as has been more often the case, inaction. 

Something remarkable just happened to health insurance costs here in Oregon. Last week, after the state’s health insurers posted their proposed premium rates for next year, two insurers publicly reversed course and moved to cut their prices.

The Supreme Court and the High Cost of Rx Drugs

By | Jesse Ellis O'Brien
Health Care Advocate

Everyone knows prescription drugs cost more than they should. But many people are surprised to learn about one of the key ways drug companies keep prices high: Paying off competitors to keep generics off the market.

Senators Hold CFPB Director Hostage, Roil Markets

By | Ed Mierzwinski
Consumer Program Director

On Friday, most Senate Republicans again sent the President a letter saying they would not confirm Richard Cordray to a full term as CFPB director unless the agency's powers and independence were first gutted. Their intransigence contributes to market uncertainty that ignores at least three things: The CFPB is here to stay; the public wants the CFPB; and, banks lose to payday lenders if the director is not confirmed.

Pages

Subscribe to Blog

PRIORITY ACTION

Take our quick survey to let us know who your health insurer is, and we'll make sure you're the first to know when they propose a rate hike — and give you a chance to speak up.
 

Support Us

Your donation supports OSPIRG’s work to stand up for consumers on the issues that matter, especially when powerful interests are blocking progress.

Consumer Alerts

Join our network and stay up to date on our campaigns, get important consumer updates, and take action on critical issues.